Drug intelligence / Profile preview

Huangqin Qingre Chubi Capsule

Development stage: Unknown
Lead developer: First Affiliated Hospital of Anhui University of Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Huangqin Qingre Chubi Capsule is a traditional Chinese medicine compound used for treating rheumatoid arthritis. It consists of five traditional Chinese medicines: Scutellaria baicalensis Georgi, Gardenia jasminoides Ellis, Coicis Semen, Semen Persicae, and Clematis chinensis Osbeck. Clinical studies show it reduces pain, joint swelling, and morning stiffness while improving joint function in RA patients. Its mechanism of action involves regulating intestinal flora, improving intestinal barrier function, inhibiting LPS translocation into blood, and modulating the CUL4B/Wnt pathway.

Brand names: Huangqin Qingre Chubi capsule
Other names: HQC

Targets

CUL4B (Cullin 4B)

Beyond the preview

Go deeper on Huangqin Qingre Chubi Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangqin Qingre Chubi Capsule.

Explore the full profile